Methods for the treatment of parkinson's disease psychosis using pimavanserin
First Claim
Patent Images
1. A method for excluding from a clinical study patients with likelihood for placebo response, the method comprising screening a group of psychosis patients by administering social interaction therapy designed for psychosis, wherein patients who respond sufficiently to the social interaction therapy are excluded from a subsequent clinical study.
2 Assignments
0 Petitions
Accused Products
Abstract
Methods for the treatment of Parkinson'"'"'s disease psychosis which comprise the administration of pimavanserin.
-
Citations
10 Claims
- 1. A method for excluding from a clinical study patients with likelihood for placebo response, the method comprising screening a group of psychosis patients by administering social interaction therapy designed for psychosis, wherein patients who respond sufficiently to the social interaction therapy are excluded from a subsequent clinical study.
-
8. A method for improvement of daytime wakefulness in a Parkinson'"'"'s disease patient, comprising the oral administration of pimavanserin, or a pharmaceutically acceptable salt thereof, to the patient in a daily dose of about 40 mg, wherein the improvement of wakefulness is measured on the Scales for Outcomes in Parkinson'"'"'s Disease—
- Sleep scale.
- View Dependent Claims (9, 10)
Specification